David Hollander - Chief R&D Officer at Aerie Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Stock Symbol
AERI
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Hollander since 8/26/2023

Holdings reported by David Hollander for Aerie Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30.7K $469K $15.25 Feb 4, 2022 Direct

Transactions reported by David Hollander for Aerie Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.